最も投資余地があるメドテックイノベーションの機会
This is the year to put medtech investment to work. With macroeconomics improving, inflation easing and organizations stabilizing, now is the time to light the powder.
Cracking genomics needs biology and engineering to find a common language
The first company to deploy cost-effective genomic measurements in mainstream medicine will not only transform healthcare, but also create lasting business value. But why has no-one cracked it yet?
The precision medicine industry must work together to transform rare disease treatment
Precision medicine is leading to transformative patient treatments – but industry collaboration is needed to make sure patients with rare diseases are not left behind.
Metamorphosis: How converging deep tech will propel business in the new bioeconomy
バイオテクノロジーや合成生物学などの新たなディープテックが、エキサイティングな新しいバイオエコノミーを形成しつつあります。本イノベーション解説では、その将来へのビジョンを提示し、拡張性と収益性が高く、レジリエントなバイオプロセスがビジネスと持続可能性にどのように役立つかを説明します。
Where does quantum technology sit as part of a system?
For many business leaders, quantum technology remains confusing and inaccessible. But it can feel more familiar when it takes its place as part of a wider system. Here Edmund Owen explains the keys to integrating quantum components into larger systems, existing value chains and business processes
Quantum computing adoption – it’s time to seize the initiative
Quantum technology commercial adoption will be gradual – but that doesn’t mean ambitious business leaders should adopt a wait and see approach.